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Abstract: This study examined the association between bone mineral density (BMD) and the rs7975232 (ApaI) poly-
morphism of the vitamin receptor D (VDR) gene. The polymorphism was detected using the real-time PCR TaqMan 
method. The rs7975232 genotype was determined in 274 postmenopausal osteoporotic Spanish women who were 
60.53±8.02 years old. The observed genotype frequencies were in agreement with Hardy-Weinberg equilibrium 
(χ2=1.85, P=0.1736). There were no significant differences in the rs7975232 genotype groups in our total sample 
of osteoporotic women regarding age, years since menopause, height, weight, and BMD at femoral neck, femoral 
trochanter and lumbar spine. Significant differences were found in menarche age (aa vs Aa; P=0.008) and BMI (aa 
vs AA; P=0.029). We conclude that the VDR gene rs7975232 polymorphism is not related to figures of bone mineral 
density in postmenopausal osteoporotic Spanish women.
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Introduction
Osteoporosis is a polygenic disorder that is 
determined by the effects of several genes, 
each with relatively modest effects on bone 
mass and other determinants of fracture risk. 
Osteoporosis is a disease of low bone mineral 
mass and microarchitectural deterioration of 
bone, which leads to increased fracture risk [1]. 
Bone mineral density (BMD) is usually used as 
a measure of bone strength, and diagnoses of 
osteoporosis are based on its analysis [1].
Previous studies in twins and families showed 
that genetic factors play an important role in 
the formation of BMD and that genetic influ-
ences can account for up to 85% of the bone 
mass, with the strongest effects in the axial 
skeleton [2-4]. Population-based studies and 
case-control studies have similarly identified 
polymorphisms in several candidate genes that 
have been associated with bone mass or osteo-
porotic fracture, including the vitamin D recep-
tor (VDR) [5], the estrogen receptor [6], regula-
tor genes of the synthesis of TGF-β1 [7] and the 
collagen type I α-1 gene [8]. Vitamin D, through 
its principal bioactive form 1,25-dihydroxyvita-
min D3 (1,25-(OH)2D3), plays a crucial role in 
bone metabolism. In 1994, Morrison et al. 
reported a strong relationship between BMD 
and restriction fragment length polymorphisms 
(RFLPs) based on BsmI endonuclease digestion 
at the vitamin D receptor (VDR) gene locus in 
Caucasian women [5]; since then, significant 
associations between common polymorphisms 
of the VDR gene, including the ApaI polymor-
phism (rs7975232), and BMD in Caucasian 
women have been reported [9, 10]. However, 
there are still conflicting results.
This study aimed to investigate the relationship 
of commonly studied polymorphisms in the VDR 
gene, rs7975232, with the BMD figures in a 
cohort of Spanish postmenopausal women.
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Methods
This was an observational, cross-sectional 
study. The present study sample comprised 
274 consecutive subjects included in the 
Caceres Database for the Diagnosis of 
Osteoporosis (CAFOR) study between 2010 and 
2011. The study was performed in accordance 
with the Declaration of Helsinki and was 
approved by the Research Ethics Committee of 
the University of Extremadura. Written informed 
consent was obtained from all the subjects.
Densitometric study
Densitometric measurements were performed 
to determine the BMD in the femoral neck (FN), 
femoral trochanter (FT) and the lumbar spine at 
the L2, L3, L4 and L2-L4 levels. Additionally, 
body weight and height were measured to cal-
culate body mass index (BMI). Densitometric 
tests were performed with the use of a 
NORLAND XR-800 (Norland Medical Systems, 
Inc.). BMD scores were expressed as grams per 
square centimeter.
Quantitative ultrasound study
We assessed ultrasound bone status using an 
ultrasound device, model DBM Sonic 1200® 
(Emsor, S.A., Madrid, Spain), which measured 
the amplitude-dependent speed of sound 
(Ad-SoS) in meters per second. We measured 
the phalanges (II-V) of the non-dominant hand 
and computed an average value. We achieved 
contact by means of standard ultrasound gel. 
Two 16-mm-diameter, 1.25-MHz transducers 
were assembled on a high-precision caliper 
that measured the distance between the 
probes. We positioned the probes on the 
mediolateral phalangeal surfaces using the 
phalanx head as a reference point. Positioning 
and repositioning the instrument was easy 
because it uses the prominences of the lower 
phalangeal epiphysis as a reference; the clip is 
placed just behind the prominences.
Statistical analysis
The allelic and genotypic frequencies were esti-
mated by gene counting, and the goodness of 
fit of the genotype distribution for Hardy-
Weinberg equilibrium (HWE) was tested using a 
chi-square (χ2) test. Values of P>0.05 indicated 
HWE. 
The statistical analysis of the results was per-
formed with SPSS 20 for Windows. Normal dis-
tributions and homogeneity of variances were 
assessed using the Kolmogorov-Smirnov and 
Levene tests, respectively. An analysis of vari-
ance (ANOVA) followed by Bonferroni’s post-hoc 
test was used to compare different genotypes 
in each SNP. An analysis of co-variance 
(ANCOVA) was used to compare the VDR geno-
types adjusted for the co-variants age, BMI, 
years since menopause, height and weight.
Results
The frequency of occurrence of the polymor-
phisms of ApaI in the studied sample was as 
follows: aa, 23.4% (n=64); Aa, 45.6% (n=125); 
and AA, 31.0% (n=85). The observed genotype 
frequencies were in agreement with Hardy-
Weinberg equilibrium (χ2=1.85, P=0.1736). The 
characteristics of the total sample are shown in 
Table 1. No significant differences were found 
between the ApaI genotypes regarding age, 
years since menopause (YSM), weight and 
height (P>0.05 between groups) (Table 2). 
Significant differences were found between the 
aa and Aa groups regarding menarche age 
(P=0.008) and between the aa and AA groups 
regarding BMI (P=0.029) (Table 2). No signifi-
cant differences were found in the crude BMD 
between the studied groups (Table 3) or after 
further adjustment for potential confounding 
factors (Table 3).
Table 1. Characteristics of the total sample
n = 274
Age (years) 60.53 ± 8.02
Menarche age (years) 13.05 ± 1.47
YSM (years) 13.80 ± 8.23
Weigth (kg) 61.81 ± 10.76
Height (m) 1.53 ± 0.059
BMI (kg/m2) 26.42 ± 4.90
Ad-SoS (m/s) 2004.280 ± 71.176
BMD FN (g/cm2) 0.705 ± 0.094
BMD TR (g/cm2) 0.556 ± 0.086
BMD L2 (g/cm2) 0.755 ± 0.088
BMD L3 (g/cm2) 0.748 ± 0.079
BMD L4 (g/cm2) 0.726 ± 0.079
BMD L2-L4 (g/cm2) 0.740 ± 0.072
Values are the mean ± SD.
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Discussion
Osteoporosis is a worldwide health issue with a 
high prevalence of disease. The ability to pre-
dict and prevent osteoporotic-related fractures 
would be a major benefit to both patients and 
the health system. Thus, finding a genetic 
marker that could predict those at the greatest 
risk of developing osteoporosis or its evolution 
is an attractive proposition.
At present, our study evaluated the different 
bone mineral density figures according to the 
rs7975232 genotype in a group of unrelated 
postmenopausal osteoporotic Spanish women. 
The ApaI polymorphism is located in the non-
coding region of the VDR gene and does not 
have an effect on the final protein product [11]. 
The A allele is correlated with enhanced mRNA 
stability or transcriptional activity and greater 
vitamin D activity [5]. Overall, this fact high-
lights the importance of understanding the 
mechanisms by which these polymorphisms 
affect VDR action. We found no association 
between the ApaI polymorphism genotype and 
BMD figures, which again contrasts with some 
of the earlier studies [12-14] but confirms other 
studies [15-18]. 
Data from a meta-analysis of Li and colleagues 
[13] suggest that the racial/ethnic genetic 
background plays a role. Indeed, in Caucasians, 
no associations with the ApaI polymorphism 
were found by a meta-analysis with either frac-
ture risk [19] or BMD [20].
In Spain, an earlier study from Bustamante and 
colleagues [21] in a cohort of 719 postmeno-
pausal women found no associations of BMD 
with the ApaI polymorphism; our results were 
more in accordance with this study.
In summary, our study suggests that BMD fig-
ures are not associated with the ApaI genotype 
in postmenopausal osteoporotic Spanish 
women and add to the hypothesis that the rel-
evance of the ApaI genotype in osteoporosis 
should be questioned. 
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